SCHEMBL380136

SCHEMBL380136

CCc1nc2[nH]c(=O)[nH]c(=O)c2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.48
XDH P47989 3/20 0.45
ADORA2B P29275 1/20 0.45
ADORA1 P30542 4/20 0.44
ADORA3 P0DMS8 3/20 0.44
ADORA2A P29274 2/20 0.44
GDA Q9Y2T3 2/20 0.40
ACHE P22303 1/20 0.40
TNKS2 Q9H2K2 1/20 0.39
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TP53 P04637 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
RPS6KA3 P51812 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1150739 0.85 XDH (0.47) MAPTXDHADORA2BADORA1ADORA3
SCHEMBL6233162 0.82 XDH (0.51) MAPTXDHADORA2BALDH1A1MAPK1
SCHEMBL3118423 0.81 XDH (0.54) MAPTXDHADORA2BHCAR2
SCHEMBL3399435 0.81 MAPT (0.48) MAPTXDHADORA2BADORA2AGDA
SCHEMBL31438586 0.81 MAPT (0.48) MAPTXDHADORA2BADORA1ADORA3
SCHEMBL5515639 0.81 ADORA2B (0.49) MAPTXDHADORA2BADORA1ADORA3
SCHEMBL6347021 0.81 MAPT (0.53) MAPTXDHADORA2BADORA1ADORA3
SCHEMBL4372319 0.80 MAPT (0.44) MAPTXDHADORA2BGDAACHE
SCHEMBL9386889 0.80 MAPT (0.44) MAPTXDHADORA2BADORA2AGDA
SCHEMBL60159 0.80 TSHR (0.46) MAPTXDHADORA2BADORA1ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3946353-A1 COMPOUNDS FOR USE IN THE TREATMENT OF ADCY5-RELATED DYSKINESIA ASSISTANCE PUBLIQUE, HOPITAUX DE PARIS (FR) 2022-02-09 EP claimed
WO-2020193567-A1 COMPOUNDS FOR USE IN THE TREATMENT OF ADCY5-RELATED DYSKINESIA ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (FR) 2020-10-01 WO claimed
US-5700369-A Process for adsorboaggregational flotation of Carlin type natural gold ore dressing GUANGZHOU INSTITUTE OF GEOCHEMISTRY CHINESE ACADEMY OF SCIENCES (CN) 1997-12-23 US claimed
CN-122029936-A Light-emitting element, display device, and method for manufacturing light-emitting element 夏普显示科技株式会社 2026-05-12 CN disclosed
CN-115745998-B Method for synthesizing gouache mushroom and analogue thereof by photocatalysis 新乡学院 2024-10-22 CN disclosed
EP-3946353-A1 COMPOUNDS FOR USE IN THE TREATMENT OF ADCY5-RELATED DYSKINESIA ASSISTANCE PUBLIQUE, HOPITAUX DE PARIS (FR) 2022-02-09 EP disclosed
EP-3765014-A1 METHODS AND COMPOSITIONS OF INHIBITING CSF1R FOR TREATING ALLERGIC INFLAMMATION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2021-01-20 EP disclosed
WO-2019204604-A1 METHODS AND COMPOSITIONS OF INHIBITING CSF1R FOR TREATING ALLERGIC INFLAMMATION THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2019-10-24 WO disclosed
CN-101861381-B Formulation for removing coloured coatings and various fouling layers from surfaces, method for preparing such an agent and cleaning method Foam & Beyond Ltd. (DE) 2016-03-30 CN disclosed
EP-2097415-B1 8-ETHINYLXANTHINE DERIVATIVES AS SELECTIVE A2A RECEPTOR ANTAGONISTS UNIV BONN (DE) 2014-10-29 EP disclosed
US-20140274855-A1 FORMULA FOR REMOVING COLOR COATS AND VARIOUS SOIL LAYERS FROM SURFACES, METHOD FOR PRODUCING THE AGENT, AND METHOD FOR CLEANING BUBBLES & BEYOND GMBH (DE) 2014-09-18 US disclosed
WO-1995007082-A1 A COMBINATION TABLET COMPRISING ACETYLSALICYLIC ACID AND A PROCESS FOR THE PREPARATION THEREOF EGIS Gyógyszergyár Rt. (HU) 1995-03-16 WO disclosed
EP-0528951-A4 HUMANIZED CDR-GRAFTED ANTI-ICAM-1 ANTIBODIES, METHODS OF PREPARATION AND USAGE THEREOF 1993-05-26 EP disclosed
EP-0528951-A1 HUMANIZED CDR-GRAFTED ANTI-ICAM-1 ANTIBODIES, METHODS OF PREPARATION AND USAGE THEREOF CELLTECH LIMITED (GB) 1993-03-03 EP disclosed
EP-0502043-A1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR. LVMH RECH (FR) 1992-09-09 EP disclosed
WO-1992007566-A2 ANTIFUNGAL ACTIVITY OF AND PREVENTION OF DRUG INDUCED NEPHROTOXICITY BY METHYLXANTHINE ANALOGUES BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-05-14 WO disclosed
EP-0480934-A1 A SLIMMING PHARMACEUTICAL COMPOSITION. DAK LAB AS (DK) 1992-04-22 EP disclosed
WO-1991016927-A1 HUMANIZED CDR-GRAFTED ANTI-ICAM-1 ANTIBODIES, METHODS OF PREPARATION AND USAGE THEREOF CELLTECH LIMITED (GB) 1991-11-14 WO disclosed
WO-1991007945-A1 UTILIZATION OF XANTHINES, OPTIONALLY INCORPORATED IN LIPOSOMES IN ORDER TO HELP THE PIGMENTATION OF SKIN OR HAIR LVMH RECHERCHE (FR) 1991-06-13 WO disclosed
WO-1991000730-A1 A SLIMMING PHARMACEUTICAL COMPOSITION DAK-LABORATORIET A/S (DK) 1991-01-24 WO disclosed